Skip to Content

Aurora Cannabis Inc ACB

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Aurora Continues to Make Progress on Cost Cuts in Q4, but Risk-Adjusted Upside Is Limited

Analyst Note

| Kristoffer Inton |

Similar to its first fiscal quarter, Aurora Cannabis continued to reduce overhead costs and capital spending while enjoying strong top line growth in the second quarter. Cannabis net revenue was up 11% over the prior year quarter to CAD 70 million, with particularly strong contributions from the international medical market where sales were up 562%.

Read Full Analysis

Company Profile

Business Description

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ‘71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Contact
4818 31 Street East, Edmonton International Airport
Edmonton, AB, T9E 0V6, Canada
T +1 844 928-7672
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Dec 31, 2020
Fiscal Year End Jun 30, 2021
Stock Type
Employees 2,380